Neuralink Corp., a Elon Musk founded neurotechnology company, has reportedly obtained clearance from the US Food & Drug Administration (FDA) to proceed with its first clinical study involving humans. Elon Musk previously described the implantable Neuralink device as a means for individuals to interact with computers using their minds. The company expressed its enthusiasm & satisfaction after receiving FDA clearance. It made the announcement through a tweet shared by Elon Musk. Musk has expressed concerns about the potential dominance of AI and aims to improve human intellectual capabilities using brain-machine interfaces.

Source: Mint May 26, 2023 21:44 UTC